Global Live Attenuated Veterinary Vaccines Market Growth 2026-2032
The global Live Attenuated Veterinary Vaccines market size is predicted to grow from US$ 431 million in 2025 to US$ 756 million in 2032; it is expected to grow at a CAGR of 8.7% from 2026 to 2032.
In 2025, global Live Attenuated Veterinary Vaccine approximately 16,943 k doses, with an average global market price of around US$ 26 per dose. Gross margin is about 47%. The cost is 14 usd. The Production is about 25,000 k doses. Live attenuated veterinary vaccines are biological products used to prevent infectious diseases in animals. They are made from pathogens that have been artificially weakened so that their disease-causing ability is greatly reduced while their capacity to stimulate an immune response remains. These vaccines usually provide strong and long-lasting immune protection and are widely used in poultry, swine, cattle, sheep, companion animals, and other animal disease prevention programs. Compared with inactivated vaccines, live attenuated vaccines often require lower doses and can induce faster immune responses, but they also require stricter control over production, storage, transportation, safety, and stability.
Live attenuated veterinary vaccines will develop toward greater safety, stability, precision, and efficiency. As large-scale farming and animal disease prevention requirements continue to rise, manufacturers will focus more on attenuation stability, duration of immunity, cross-protection, and cold-chain stability to reduce risks such as reversion to virulence, shedding, and environmental transmission. At the same time, genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will drive product innovation, enabling broader protection against multiple pathogens or serotypes. In application, mass vaccination methods such as spray, drinking water, and intranasal delivery will become more widely used and integrated with digital disease monitoring and precise vaccination programs to improve efficiency across poultry, swine, cattle, sheep, and companion animal markets.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Veterinary Vaccines Industry Forecast? looks at past sales and reviews total world Live Attenuated Veterinary Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Veterinary Vaccines sales for 2026 through 2032. With Live Attenuated Veterinary Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Veterinary Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Veterinary Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Veterinary Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Veterinary Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Veterinary Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Veterinary Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Veterinary Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Live Attenuated Veterinary Vaccines market?
What factors are driving Live Attenuated Veterinary Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Attenuated Veterinary Vaccines market opportunities vary by end market size?
How does Live Attenuated Veterinary Vaccines break out by Type, by Application?
In 2025, global Live Attenuated Veterinary Vaccine approximately 16,943 k doses, with an average global market price of around US$ 26 per dose. Gross margin is about 47%. The cost is 14 usd. The Production is about 25,000 k doses. Live attenuated veterinary vaccines are biological products used to prevent infectious diseases in animals. They are made from pathogens that have been artificially weakened so that their disease-causing ability is greatly reduced while their capacity to stimulate an immune response remains. These vaccines usually provide strong and long-lasting immune protection and are widely used in poultry, swine, cattle, sheep, companion animals, and other animal disease prevention programs. Compared with inactivated vaccines, live attenuated vaccines often require lower doses and can induce faster immune responses, but they also require stricter control over production, storage, transportation, safety, and stability.
Live attenuated veterinary vaccines will develop toward greater safety, stability, precision, and efficiency. As large-scale farming and animal disease prevention requirements continue to rise, manufacturers will focus more on attenuation stability, duration of immunity, cross-protection, and cold-chain stability to reduce risks such as reversion to virulence, shedding, and environmental transmission. At the same time, genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will drive product innovation, enabling broader protection against multiple pathogens or serotypes. In application, mass vaccination methods such as spray, drinking water, and intranasal delivery will become more widely used and integrated with digital disease monitoring and precise vaccination programs to improve efficiency across poultry, swine, cattle, sheep, and companion animal markets.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Veterinary Vaccines Industry Forecast? looks at past sales and reviews total world Live Attenuated Veterinary Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Veterinary Vaccines sales for 2026 through 2032. With Live Attenuated Veterinary Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Veterinary Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Veterinary Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Veterinary Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Veterinary Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Veterinary Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Veterinary Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Veterinary Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Poultry
- Ruminants
- Feline
- Canine
- Viral Live Attenuated Vaccines
- Bacterial Live Attenuated Vaccines
- Parasitic Live Attenuated Vaccines
- Monovalent Live Attenuated Vaccines
- Multivalent Live Attenuated Vaccines
- Combination Live Attenuated Vaccines
- Veterinary Hospital
- Laboratory
- CROs
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Ceva Sant? Animale
- Boehringer Ingelheim Animal Health
- MSD Animal Health
- Virbac
- HIPRA
- Vetoquinol
- Phibro Animal Health
- IDT Biologika
- Vaxxinova
- KBNP Inc.
- China Pharmaceutical Group Animal Health Co., Ltd.
- Jinyu Bio-technology Co., Ltd.
What is the 10-year outlook for the global Live Attenuated Veterinary Vaccines market?
What factors are driving Live Attenuated Veterinary Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Attenuated Veterinary Vaccines market opportunities vary by end market size?
How does Live Attenuated Veterinary Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Veterinary Vaccines Segment by Type
2.2.1 Poultry
2.2.2 Ruminants
2.2.3 Feline
2.2.4 Canine
2.2.5 Live Attenuated Veterinary Vaccines Sales by Type
2.2.5.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
2.2.5.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Live Attenuated Veterinary Vaccines Sale Price by Type (2021-2026)
2.3 Live Attenuated Veterinary Vaccines Segment by Pathogen
2.3.1 Viral Live Attenuated Vaccines
2.3.2 Bacterial Live Attenuated Vaccines
2.3.3 Parasitic Live Attenuated Vaccines
2.3.4 Live Attenuated Veterinary Vaccines Sales by Pathogen
2.3.4.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen (2021-2026)
2.3.4.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Pathogen (2021-2026)
2.3.4.3 Global Live Attenuated Veterinary Vaccines Sale Price by Pathogen (2021-2026)
2.4 Live Attenuated Veterinary Vaccines Segment by Vaccine Combination
2.4.1 Monovalent Live Attenuated Vaccines
2.4.2 Multivalent Live Attenuated Vaccines
2.4.3 Combination Live Attenuated Vaccines
2.4.4 Live Attenuated Veterinary Vaccines Sales by Vaccine Combination
2.4.4.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination (2021-2026)
2.4.4.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Vaccine Combination (2021-2026)
2.4.4.3 Global Live Attenuated Veterinary Vaccines Sale Price by Vaccine Combination (2021-2026)
2.5 Live Attenuated Veterinary Vaccines Segment by Application
2.5.1 Veterinary Hospital
2.5.2 Laboratory
2.5.3 CROs
2.5.4 Others
2.5.5 Live Attenuated Veterinary Vaccines Sales by Application
2.5.5.1 Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Live Attenuated Veterinary Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Veterinary Vaccines Breakdown Data by Company
3.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Veterinary Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Veterinary Vaccines Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Veterinary Vaccines Sale Price by Company
3.4 Key Manufacturers Live Attenuated Veterinary Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Veterinary Vaccines Product Location Distribution
3.4.2 Players Live Attenuated Veterinary Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED VETERINARY VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Veterinary Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Veterinary Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Veterinary Vaccines Sales Growth
4.4 APAC Live Attenuated Veterinary Vaccines Sales Growth
4.5 Europe Live Attenuated Veterinary Vaccines Sales Growth
4.6 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Veterinary Vaccines Sales by Country
5.1.1 Americas Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
5.3 Americas Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Veterinary Vaccines Sales by Region
6.1.1 APAC Live Attenuated Veterinary Vaccines Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Veterinary Vaccines Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
6.3 APAC Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Veterinary Vaccines by Country
7.1.1 Europe Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
7.3 Europe Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Veterinary Vaccines by Country
8.1.1 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Veterinary Vaccines
10.3 Manufacturing Process Analysis of Live Attenuated Veterinary Vaccines
10.4 Industry Chain Structure of Live Attenuated Veterinary Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Veterinary Vaccines Distributors
11.3 Live Attenuated Veterinary Vaccines Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED VETERINARY VACCINES BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Veterinary Vaccines Market Size Forecast by Region
12.1.1 Global Live Attenuated Veterinary Vaccines Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Veterinary Vaccines Forecast by Type (2027-2032)
12.7 Global Live Attenuated Veterinary Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.1.3 Zoetis Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.5.3 Virbac Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 HIPRA
13.6.1 HIPRA Company Information
13.6.2 HIPRA Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.6.3 HIPRA Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HIPRA Main Business Overview
13.6.5 HIPRA Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.7.3 Vetoquinol Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Phibro Animal Health
13.8.1 Phibro Animal Health Company Information
13.8.2 Phibro Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.8.3 Phibro Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Phibro Animal Health Main Business Overview
13.8.5 Phibro Animal Health Latest Developments
13.9 IDT Biologika
13.9.1 IDT Biologika Company Information
13.9.2 IDT Biologika Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.9.3 IDT Biologika Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IDT Biologika Main Business Overview
13.9.5 IDT Biologika Latest Developments
13.10 Vaxxinova
13.10.1 Vaxxinova Company Information
13.10.2 Vaxxinova Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.10.3 Vaxxinova Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vaxxinova Main Business Overview
13.10.5 Vaxxinova Latest Developments
13.11 KBNP Inc.
13.11.1 KBNP Inc. Company Information
13.11.2 KBNP Inc. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.11.3 KBNP Inc. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KBNP Inc. Main Business Overview
13.11.5 KBNP Inc. Latest Developments
13.12 China Pharmaceutical Group Animal Health Co., Ltd.
13.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Company Information
13.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Main Business Overview
13.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
13.13 Jinyu Bio-technology Co., Ltd.
13.13.1 Jinyu Bio-technology Co., Ltd. Company Information
13.13.2 Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.13.3 Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jinyu Bio-technology Co., Ltd. Main Business Overview
13.13.5 Jinyu Bio-technology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Veterinary Vaccines Segment by Type
2.2.1 Poultry
2.2.2 Ruminants
2.2.3 Feline
2.2.4 Canine
2.2.5 Live Attenuated Veterinary Vaccines Sales by Type
2.2.5.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
2.2.5.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Live Attenuated Veterinary Vaccines Sale Price by Type (2021-2026)
2.3 Live Attenuated Veterinary Vaccines Segment by Pathogen
2.3.1 Viral Live Attenuated Vaccines
2.3.2 Bacterial Live Attenuated Vaccines
2.3.3 Parasitic Live Attenuated Vaccines
2.3.4 Live Attenuated Veterinary Vaccines Sales by Pathogen
2.3.4.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen (2021-2026)
2.3.4.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Pathogen (2021-2026)
2.3.4.3 Global Live Attenuated Veterinary Vaccines Sale Price by Pathogen (2021-2026)
2.4 Live Attenuated Veterinary Vaccines Segment by Vaccine Combination
2.4.1 Monovalent Live Attenuated Vaccines
2.4.2 Multivalent Live Attenuated Vaccines
2.4.3 Combination Live Attenuated Vaccines
2.4.4 Live Attenuated Veterinary Vaccines Sales by Vaccine Combination
2.4.4.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination (2021-2026)
2.4.4.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Vaccine Combination (2021-2026)
2.4.4.3 Global Live Attenuated Veterinary Vaccines Sale Price by Vaccine Combination (2021-2026)
2.5 Live Attenuated Veterinary Vaccines Segment by Application
2.5.1 Veterinary Hospital
2.5.2 Laboratory
2.5.3 CROs
2.5.4 Others
2.5.5 Live Attenuated Veterinary Vaccines Sales by Application
2.5.5.1 Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Live Attenuated Veterinary Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Veterinary Vaccines Breakdown Data by Company
3.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Veterinary Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Veterinary Vaccines Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Veterinary Vaccines Sale Price by Company
3.4 Key Manufacturers Live Attenuated Veterinary Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Veterinary Vaccines Product Location Distribution
3.4.2 Players Live Attenuated Veterinary Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED VETERINARY VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Veterinary Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Veterinary Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Veterinary Vaccines Sales Growth
4.4 APAC Live Attenuated Veterinary Vaccines Sales Growth
4.5 Europe Live Attenuated Veterinary Vaccines Sales Growth
4.6 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Veterinary Vaccines Sales by Country
5.1.1 Americas Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
5.3 Americas Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Veterinary Vaccines Sales by Region
6.1.1 APAC Live Attenuated Veterinary Vaccines Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Veterinary Vaccines Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
6.3 APAC Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Veterinary Vaccines by Country
7.1.1 Europe Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
7.3 Europe Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Veterinary Vaccines by Country
8.1.1 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Veterinary Vaccines
10.3 Manufacturing Process Analysis of Live Attenuated Veterinary Vaccines
10.4 Industry Chain Structure of Live Attenuated Veterinary Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Veterinary Vaccines Distributors
11.3 Live Attenuated Veterinary Vaccines Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED VETERINARY VACCINES BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Veterinary Vaccines Market Size Forecast by Region
12.1.1 Global Live Attenuated Veterinary Vaccines Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Veterinary Vaccines Forecast by Type (2027-2032)
12.7 Global Live Attenuated Veterinary Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.1.3 Zoetis Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.5.3 Virbac Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 HIPRA
13.6.1 HIPRA Company Information
13.6.2 HIPRA Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.6.3 HIPRA Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HIPRA Main Business Overview
13.6.5 HIPRA Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.7.3 Vetoquinol Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Phibro Animal Health
13.8.1 Phibro Animal Health Company Information
13.8.2 Phibro Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.8.3 Phibro Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Phibro Animal Health Main Business Overview
13.8.5 Phibro Animal Health Latest Developments
13.9 IDT Biologika
13.9.1 IDT Biologika Company Information
13.9.2 IDT Biologika Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.9.3 IDT Biologika Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IDT Biologika Main Business Overview
13.9.5 IDT Biologika Latest Developments
13.10 Vaxxinova
13.10.1 Vaxxinova Company Information
13.10.2 Vaxxinova Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.10.3 Vaxxinova Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vaxxinova Main Business Overview
13.10.5 Vaxxinova Latest Developments
13.11 KBNP Inc.
13.11.1 KBNP Inc. Company Information
13.11.2 KBNP Inc. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.11.3 KBNP Inc. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KBNP Inc. Main Business Overview
13.11.5 KBNP Inc. Latest Developments
13.12 China Pharmaceutical Group Animal Health Co., Ltd.
13.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Company Information
13.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Main Business Overview
13.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
13.13 Jinyu Bio-technology Co., Ltd.
13.13.1 Jinyu Bio-technology Co., Ltd. Company Information
13.13.2 Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
13.13.3 Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jinyu Bio-technology Co., Ltd. Main Business Overview
13.13.5 Jinyu Bio-technology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Attenuated Veterinary Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Veterinary Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Poultry
Table 4. Major Players of Ruminants
Table 5. Major Players of Feline
Table 6. Major Players of Canine
Table 7. Global Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 8. Global Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Veterinary Vaccines Revenue by Type (2021-2026) & ($ million)
Table 10. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Type (2021-2026)
Table 11. Global Live Attenuated Veterinary Vaccines Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Viral Live Attenuated Vaccines
Table 13. Major Players of Bacterial Live Attenuated Vaccines
Table 14. Major Players of Parasitic Live Attenuated Vaccines
Table 15. Global Live Attenuated Veterinary Vaccines Sales by Pathogen (2021-2026) & (K Dose)
Table 16. Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen (2021-2026)
Table 17. Global Live Attenuated Veterinary Vaccines Revenue by Pathogen (2021-2026) & ($ million)
Table 18. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Pathogen (2021-2026)
Table 19. Global Live Attenuated Veterinary Vaccines Sale Price by Pathogen (2021-2026) & (US$/Dose)
Table 20. Major Players of Monovalent Live Attenuated Vaccines
Table 21. Major Players of Multivalent Live Attenuated Vaccines
Table 22. Major Players of Combination Live Attenuated Vaccines
Table 23. Global Live Attenuated Veterinary Vaccines Sales by Vaccine Combination (2021-2026) & (K Dose)
Table 24. Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination (2021-2026)
Table 25. Global Live Attenuated Veterinary Vaccines Revenue by Vaccine Combination (2021-2026) & ($ million)
Table 26. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Vaccine Combination (2021-2026)
Table 27. Global Live Attenuated Veterinary Vaccines Sale Price by Vaccine Combination (2021-2026) & (US$/Dose)
Table 28. Global Live Attenuated Veterinary Vaccines Sale by Application (2021-2026) & (K Dose)
Table 29. Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2021-2026)
Table 30. Global Live Attenuated Veterinary Vaccines Revenue by Application (2021-2026) & ($ million)
Table 31. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Application (2021-2026)
Table 32. Global Live Attenuated Veterinary Vaccines Sale Price by Application (2021-2026) & (US$/Dose)
Table 33. Global Live Attenuated Veterinary Vaccines Sales by Company (2021-2026) & (K Dose)
Table 34. Global Live Attenuated Veterinary Vaccines Sales Market Share by Company (2021-2026)
Table 35. Global Live Attenuated Veterinary Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company (2021-2026)
Table 37. Global Live Attenuated Veterinary Vaccines Sale Price by Company (2021-2026) & (US$/Dose)
Table 38. Key Manufacturers Live Attenuated Veterinary Vaccines Producing Area Distribution and Sales Area
Table 39. Players Live Attenuated Veterinary Vaccines Products Offered
Table 40. Live Attenuated Veterinary Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Live Attenuated Veterinary Vaccines Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Live Attenuated Veterinary Vaccines Sales Market Share Geographic Region (2021-2026)
Table 45. Global Live Attenuated Veterinary Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Live Attenuated Veterinary Vaccines Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2021-2026)
Table 49. Global Live Attenuated Veterinary Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Country (2021-2026)
Table 53. Americas Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Live Attenuated Veterinary Vaccines Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Region (2021-2026)
Table 58. APAC Live Attenuated Veterinary Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Live Attenuated Veterinary Vaccines
Table 70. Key Market Challenges & Risks of Live Attenuated Veterinary Vaccines
Table 71. Key Industry Trends of Live Attenuated Veterinary Vaccines
Table 72. Live Attenuated Veterinary Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Live Attenuated Veterinary Vaccines Distributors List
Table 75. Live Attenuated Veterinary Vaccines Customer List
Table 76. Global Live Attenuated Veterinary Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Live Attenuated Veterinary Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Live Attenuated Veterinary Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Live Attenuated Veterinary Vaccines Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Live Attenuated Veterinary Vaccines Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Zoetis Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Zoetis Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 92. Zoetis Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. Zoetis Main Business
Table 94. Zoetis Latest Developments
Table 95. Ceva Sant? Animale Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Ceva Sant? Animale Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 97. Ceva Sant? Animale Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Ceva Sant? Animale Main Business
Table 99. Ceva Sant? Animale Latest Developments
Table 100. Boehringer Ingelheim Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 102. Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. Boehringer Ingelheim Animal Health Main Business
Table 104. Boehringer Ingelheim Animal Health Latest Developments
Table 105. MSD Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. MSD Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 107. MSD Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. MSD Animal Health Main Business
Table 109. MSD Animal Health Latest Developments
Table 110. Virbac Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Virbac Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 112. Virbac Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Virbac Main Business
Table 114. Virbac Latest Developments
Table 115. HIPRA Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. HIPRA Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 117. HIPRA Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. HIPRA Main Business
Table 119. HIPRA Latest Developments
Table 120. Vetoquinol Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Vetoquinol Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 122. Vetoquinol Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. Vetoquinol Main Business
Table 124. Vetoquinol Latest Developments
Table 125. Phibro Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Phibro Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 127. Phibro Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Phibro Animal Health Main Business
Table 129. Phibro Animal Health Latest Developments
Table 130. IDT Biologika Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. IDT Biologika Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 132. IDT Biologika Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. IDT Biologika Main Business
Table 134. IDT Biologika Latest Developments
Table 135. Vaxxinova Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Vaxxinova Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 137. Vaxxinova Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. Vaxxinova Main Business
Table 139. Vaxxinova Latest Developments
Table 140. KBNP Inc. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. KBNP Inc. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 142. KBNP Inc. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. KBNP Inc. Main Business
Table 144. KBNP Inc. Latest Developments
Table 145. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 147. China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. China Pharmaceutical Group Animal Health Co., Ltd. Main Business
Table 149. China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
Table 150. Jinyu Bio-technology Co., Ltd. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 152. Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 153. Jinyu Bio-technology Co., Ltd. Main Business
Table 154. Jinyu Bio-technology Co., Ltd. Latest Developments
Table 1. Live Attenuated Veterinary Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Veterinary Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Poultry
Table 4. Major Players of Ruminants
Table 5. Major Players of Feline
Table 6. Major Players of Canine
Table 7. Global Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 8. Global Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Veterinary Vaccines Revenue by Type (2021-2026) & ($ million)
Table 10. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Type (2021-2026)
Table 11. Global Live Attenuated Veterinary Vaccines Sale Price by Type (2021-2026) & (US$/Dose)
Table 12. Major Players of Viral Live Attenuated Vaccines
Table 13. Major Players of Bacterial Live Attenuated Vaccines
Table 14. Major Players of Parasitic Live Attenuated Vaccines
Table 15. Global Live Attenuated Veterinary Vaccines Sales by Pathogen (2021-2026) & (K Dose)
Table 16. Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen (2021-2026)
Table 17. Global Live Attenuated Veterinary Vaccines Revenue by Pathogen (2021-2026) & ($ million)
Table 18. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Pathogen (2021-2026)
Table 19. Global Live Attenuated Veterinary Vaccines Sale Price by Pathogen (2021-2026) & (US$/Dose)
Table 20. Major Players of Monovalent Live Attenuated Vaccines
Table 21. Major Players of Multivalent Live Attenuated Vaccines
Table 22. Major Players of Combination Live Attenuated Vaccines
Table 23. Global Live Attenuated Veterinary Vaccines Sales by Vaccine Combination (2021-2026) & (K Dose)
Table 24. Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination (2021-2026)
Table 25. Global Live Attenuated Veterinary Vaccines Revenue by Vaccine Combination (2021-2026) & ($ million)
Table 26. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Vaccine Combination (2021-2026)
Table 27. Global Live Attenuated Veterinary Vaccines Sale Price by Vaccine Combination (2021-2026) & (US$/Dose)
Table 28. Global Live Attenuated Veterinary Vaccines Sale by Application (2021-2026) & (K Dose)
Table 29. Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2021-2026)
Table 30. Global Live Attenuated Veterinary Vaccines Revenue by Application (2021-2026) & ($ million)
Table 31. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Application (2021-2026)
Table 32. Global Live Attenuated Veterinary Vaccines Sale Price by Application (2021-2026) & (US$/Dose)
Table 33. Global Live Attenuated Veterinary Vaccines Sales by Company (2021-2026) & (K Dose)
Table 34. Global Live Attenuated Veterinary Vaccines Sales Market Share by Company (2021-2026)
Table 35. Global Live Attenuated Veterinary Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company (2021-2026)
Table 37. Global Live Attenuated Veterinary Vaccines Sale Price by Company (2021-2026) & (US$/Dose)
Table 38. Key Manufacturers Live Attenuated Veterinary Vaccines Producing Area Distribution and Sales Area
Table 39. Players Live Attenuated Veterinary Vaccines Products Offered
Table 40. Live Attenuated Veterinary Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Live Attenuated Veterinary Vaccines Sales by Geographic Region (2021-2026) & (K Dose)
Table 44. Global Live Attenuated Veterinary Vaccines Sales Market Share Geographic Region (2021-2026)
Table 45. Global Live Attenuated Veterinary Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Live Attenuated Veterinary Vaccines Sales by Country/Region (2021-2026) & (K Dose)
Table 48. Global Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2021-2026)
Table 49. Global Live Attenuated Veterinary Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 52. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Country (2021-2026)
Table 53. Americas Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 55. Americas Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 56. APAC Live Attenuated Veterinary Vaccines Sales by Region (2021-2026) & (K Dose)
Table 57. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Region (2021-2026)
Table 58. APAC Live Attenuated Veterinary Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 60. APAC Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 61. Europe Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 62. Europe Live Attenuated Veterinary Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 64. Europe Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 65. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Country (2021-2026) & (K Dose)
Table 66. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Type (2021-2026) & (K Dose)
Table 68. Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Application (2021-2026) & (K Dose)
Table 69. Key Market Drivers & Growth Opportunities of Live Attenuated Veterinary Vaccines
Table 70. Key Market Challenges & Risks of Live Attenuated Veterinary Vaccines
Table 71. Key Industry Trends of Live Attenuated Veterinary Vaccines
Table 72. Live Attenuated Veterinary Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Live Attenuated Veterinary Vaccines Distributors List
Table 75. Live Attenuated Veterinary Vaccines Customer List
Table 76. Global Live Attenuated Veterinary Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 77. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 79. Americas Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Live Attenuated Veterinary Vaccines Sales Forecast by Region (2027-2032) & (K Dose)
Table 81. APAC Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 83. Europe Live Attenuated Veterinary Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Forecast by Country (2027-2032) & (K Dose)
Table 85. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Live Attenuated Veterinary Vaccines Sales Forecast by Type (2027-2032) & (K Dose)
Table 87. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Live Attenuated Veterinary Vaccines Sales Forecast by Application (2027-2032) & (K Dose)
Table 89. Global Live Attenuated Veterinary Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Zoetis Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Zoetis Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 92. Zoetis Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. Zoetis Main Business
Table 94. Zoetis Latest Developments
Table 95. Ceva Sant? Animale Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Ceva Sant? Animale Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 97. Ceva Sant? Animale Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Ceva Sant? Animale Main Business
Table 99. Ceva Sant? Animale Latest Developments
Table 100. Boehringer Ingelheim Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 102. Boehringer Ingelheim Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. Boehringer Ingelheim Animal Health Main Business
Table 104. Boehringer Ingelheim Animal Health Latest Developments
Table 105. MSD Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. MSD Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 107. MSD Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. MSD Animal Health Main Business
Table 109. MSD Animal Health Latest Developments
Table 110. Virbac Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Virbac Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 112. Virbac Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Virbac Main Business
Table 114. Virbac Latest Developments
Table 115. HIPRA Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. HIPRA Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 117. HIPRA Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. HIPRA Main Business
Table 119. HIPRA Latest Developments
Table 120. Vetoquinol Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Vetoquinol Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 122. Vetoquinol Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. Vetoquinol Main Business
Table 124. Vetoquinol Latest Developments
Table 125. Phibro Animal Health Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Phibro Animal Health Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 127. Phibro Animal Health Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Phibro Animal Health Main Business
Table 129. Phibro Animal Health Latest Developments
Table 130. IDT Biologika Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. IDT Biologika Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 132. IDT Biologika Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. IDT Biologika Main Business
Table 134. IDT Biologika Latest Developments
Table 135. Vaxxinova Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Vaxxinova Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 137. Vaxxinova Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. Vaxxinova Main Business
Table 139. Vaxxinova Latest Developments
Table 140. KBNP Inc. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. KBNP Inc. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 142. KBNP Inc. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. KBNP Inc. Main Business
Table 144. KBNP Inc. Latest Developments
Table 145. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 147. China Pharmaceutical Group Animal Health Co., Ltd. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. China Pharmaceutical Group Animal Health Co., Ltd. Main Business
Table 149. China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
Table 150. Jinyu Bio-technology Co., Ltd. Basic Information, Live Attenuated Veterinary Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Product Portfolios and Specifications
Table 152. Jinyu Bio-technology Co., Ltd. Live Attenuated Veterinary Vaccines Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 153. Jinyu Bio-technology Co., Ltd. Main Business
Table 154. Jinyu Bio-technology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Live Attenuated Veterinary Vaccines
Figure 2. Live Attenuated Veterinary Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Veterinary Vaccines Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Live Attenuated Veterinary Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Veterinary Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Poultry
Figure 12. Product Picture of Ruminants
Figure 13. Product Picture of Feline
Figure 14. Product Picture of Canine
Figure 15. Global Live Attenuated Veterinary Vaccines Sales Market Share by Type in 2026
Figure 16. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Viral Live Attenuated Vaccines
Figure 18. Product Picture of Bacterial Live Attenuated Vaccines
Figure 19. Product Picture of Parasitic Live Attenuated Vaccines
Figure 20. Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen in 2026
Figure 21. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Pathogen (2021-2026)
Figure 22. Product Picture of Monovalent Live Attenuated Vaccines
Figure 23. Product Picture of Multivalent Live Attenuated Vaccines
Figure 24. Product Picture of Combination Live Attenuated Vaccines
Figure 25. Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination in 2026
Figure 26. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Vaccine Combination (2021-2026)
Figure 27. Live Attenuated Veterinary Vaccines Consumed in Veterinary Hospital
Figure 28. Global Live Attenuated Veterinary Vaccines Market: Veterinary Hospital (2021-2026) & (K Dose)
Figure 29. Live Attenuated Veterinary Vaccines Consumed in Laboratory
Figure 30. Global Live Attenuated Veterinary Vaccines Market: Laboratory (2021-2026) & (K Dose)
Figure 31. Live Attenuated Veterinary Vaccines Consumed in CROs
Figure 32. Global Live Attenuated Veterinary Vaccines Market: CROs (2021-2026) & (K Dose)
Figure 33. Live Attenuated Veterinary Vaccines Consumed in Others
Figure 34. Global Live Attenuated Veterinary Vaccines Market: Others (2021-2026) & (K Dose)
Figure 35. Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2025)
Figure 36. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Application in 2025
Figure 37. Live Attenuated Veterinary Vaccines Sales by Company in 2025 (K Dose)
Figure 38. Global Live Attenuated Veterinary Vaccines Sales Market Share by Company in 2025
Figure 39. Live Attenuated Veterinary Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Live Attenuated Veterinary Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 44. Americas Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 45. APAC Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 46. APAC Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 47. Europe Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 48. Europe Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 50. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Figure 53. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 54. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 55. United States Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Live Attenuated Veterinary Vaccines Revenue Market Share by Region (2021-2026)
Figure 61. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 62. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 63. China Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. India Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Figure 72. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 73. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 74. Germany Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 75. France Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 82. Egypt Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Live Attenuated Veterinary Vaccines in 2026
Figure 88. Manufacturing Process Analysis of Live Attenuated Veterinary Vaccines
Figure 89. Industry Chain Structure of Live Attenuated Veterinary Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Live Attenuated Veterinary Vaccines Sales Market Forecast by Region (2027-2032)
Figure 92. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Live Attenuated Veterinary Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Live Attenuated Veterinary Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Live Attenuated Veterinary Vaccines
Figure 2. Live Attenuated Veterinary Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Veterinary Vaccines Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Live Attenuated Veterinary Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Veterinary Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Veterinary Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Poultry
Figure 12. Product Picture of Ruminants
Figure 13. Product Picture of Feline
Figure 14. Product Picture of Canine
Figure 15. Global Live Attenuated Veterinary Vaccines Sales Market Share by Type in 2026
Figure 16. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Viral Live Attenuated Vaccines
Figure 18. Product Picture of Bacterial Live Attenuated Vaccines
Figure 19. Product Picture of Parasitic Live Attenuated Vaccines
Figure 20. Global Live Attenuated Veterinary Vaccines Sales Market Share by Pathogen in 2026
Figure 21. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Pathogen (2021-2026)
Figure 22. Product Picture of Monovalent Live Attenuated Vaccines
Figure 23. Product Picture of Multivalent Live Attenuated Vaccines
Figure 24. Product Picture of Combination Live Attenuated Vaccines
Figure 25. Global Live Attenuated Veterinary Vaccines Sales Market Share by Vaccine Combination in 2026
Figure 26. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Vaccine Combination (2021-2026)
Figure 27. Live Attenuated Veterinary Vaccines Consumed in Veterinary Hospital
Figure 28. Global Live Attenuated Veterinary Vaccines Market: Veterinary Hospital (2021-2026) & (K Dose)
Figure 29. Live Attenuated Veterinary Vaccines Consumed in Laboratory
Figure 30. Global Live Attenuated Veterinary Vaccines Market: Laboratory (2021-2026) & (K Dose)
Figure 31. Live Attenuated Veterinary Vaccines Consumed in CROs
Figure 32. Global Live Attenuated Veterinary Vaccines Market: CROs (2021-2026) & (K Dose)
Figure 33. Live Attenuated Veterinary Vaccines Consumed in Others
Figure 34. Global Live Attenuated Veterinary Vaccines Market: Others (2021-2026) & (K Dose)
Figure 35. Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2025)
Figure 36. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Application in 2025
Figure 37. Live Attenuated Veterinary Vaccines Sales by Company in 2025 (K Dose)
Figure 38. Global Live Attenuated Veterinary Vaccines Sales Market Share by Company in 2025
Figure 39. Live Attenuated Veterinary Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Live Attenuated Veterinary Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Live Attenuated Veterinary Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 44. Americas Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 45. APAC Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 46. APAC Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 47. Europe Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 48. Europe Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Live Attenuated Veterinary Vaccines Sales 2021-2026 (K Dose)
Figure 50. Middle East & Africa Live Attenuated Veterinary Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Figure 53. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 54. Americas Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 55. United States Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Live Attenuated Veterinary Vaccines Revenue Market Share by Region (2021-2026)
Figure 61. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 62. APAC Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 63. China Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. India Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Live Attenuated Veterinary Vaccines Revenue Market Share by Country (2021-2026)
Figure 72. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 73. Europe Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 74. Germany Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 75. France Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Live Attenuated Veterinary Vaccines Sales Market Share by Application (2021-2026)
Figure 82. Egypt Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Live Attenuated Veterinary Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Live Attenuated Veterinary Vaccines in 2026
Figure 88. Manufacturing Process Analysis of Live Attenuated Veterinary Vaccines
Figure 89. Industry Chain Structure of Live Attenuated Veterinary Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Live Attenuated Veterinary Vaccines Sales Market Forecast by Region (2027-2032)
Figure 92. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Live Attenuated Veterinary Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Live Attenuated Veterinary Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Live Attenuated Veterinary Vaccines Revenue Market Share Forecast by Application (2027-2032)
